Cote d'Ivoire Pharmaceuticals & Healthcare Q4 2018
Côte d'Ivoire's pharmaceutical market will remain highly challenging for multinational drugmakers. While the nascentnature of the sector holds opportunities for firms to establish a first-mover advantage, key factors such as limited access tomedicines and a lack of healthcare infrastructure will limit commercial opportunities. We hold a more positive long-term outlook onthe back of economic prosperity and the push for healthcare self-sufficiency, although this will take time to materialise into anytangible benefits.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook